Form 4: SIGA General Counsel Reports RSU Vesting, New Grant

SIGA Technologies General Counsel Larry R. Miller reported the vesting of restricted stock units and subsequent share transactions for tax obligations, alongside a new RSU grant.

Summary

• Larry R. Miller, General Counsel of SIGA Technologies Inc., reported changes in his beneficial ownership on March 13, 2026.
• Acquired 21,261 shares of common stock from the vesting of one-third of restricted stock units (RSUs) originally granted on March 13, 2025.
• Disposed of 11,187 shares of common stock at a price of $5.26 per share to satisfy tax withholding obligations associated with the RSU vesting.
• Acquired 68,060 new Restricted Stock Units.
• Following these transactions, Mr. Miller directly owns 48,518 shares of common stock and 68,060 Restricted Stock Units.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a routine and expected insider transaction related to executive compensation, with the new RSU grant indicating continued alignment of management incentives, which is mildly positive.

Positives

• Vesting of 21,261 restricted stock units (RSUs) for General Counsel Larry R. Miller, converting into common stock, reflects a component of his compensation package.
• Grant of 68,060 new Restricted Stock Units to Mr. Miller indicates continued long-term incentive and alignment with shareholder interests.

Negatives

• Disposition of 11,187 shares of common stock at $5.26 per share to satisfy tax withholding obligations, which reduces direct share ownership.

Future Outlook

The newly acquired 68,060 Restricted Stock Units will vest over three years, with one-third vesting on each of the first three anniversaries of the grant date, providing future equity compensation.

Industry Context

StockSavvy.ai notes that routine insider filings like Form 4, detailing RSU vesting and tax-related sales, are common in executive compensation structures across the biotechnology and pharmaceutical industries. These transactions typically reflect pre-scheduled events rather than discretionary trading based on new material information.

Comparison to Industry Standards

• Executive compensation packages often include equity components like Restricted Stock Units (RSUs) to align management incentives with long-term company performance, a practice common among biotech peers such as Moderna (MRNA) or Pfizer (PFE).
• The practice of 'net settlement' or 'sell-to-cover' for tax obligations upon RSU vesting is a standard mechanism to manage tax liabilities, observed across various industries and companies of similar market capitalization.

Stakeholder Impact

• Shareholders: The transactions are routine and reflect standard executive compensation practices, with a minor dilution from RSU vesting offset by the incentive alignment.
• Management (Larry R. Miller): Receives equity compensation, aligning his interests with the company's long-term performance.

Next Steps

• Future vesting of the remaining two-thirds of RSUs granted on March 13, 2025, on their respective anniversaries.
• Future vesting of the newly granted 68,060 RSUs over the next three years, with one-third vesting annually.

Key Dates

Recommendation

This Form 4 details a routine insider transaction involving the vesting of restricted stock units and subsequent share sales for tax purposes, along with a new RSU grant. These are standard components of executive compensation and do not provide new material information that would warrant a change in investment recommendation. The transactions reflect pre-scheduled events rather than discretionary trading based on new company developments.

Keywords

SIGA, SIGA Technologies, Form 4, insider transaction, RSU vesting, restricted stock units, executive compensation, Larry R. Miller, General Counsel